Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

The concentration of total nucleated cells in harvested bone marrow for transplantation has decreased over time.

Prokopishyn NL, Logan BR, Kiefer DM, Sees JA, Chitphakdithai P, Ahmed IA, Anderlini PN, Beitinjaneh AM, Bredeson C, Cerny J, Chhabra S, Daly A, Diaz MA, Farhadfar N, Frangoul HA, Ganguly S, Gastineau DA, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Norkin M, Olsson RF, Papari M, Savani BN, Szer J, Waller EK, Wirk B, Yared JA, Pulsipher MA, Shah NN, Switzer GE, O'Donnell PV, Confer DL, Shaw BE.

Biol Blood Marrow Transplant. 2019 Feb 1. pii: S1083-8791(19)30092-8. doi: 10.1016/j.bbmt.2019.01.034. [Epub ahead of print]

PMID:
30716454
2.

Author Correction: Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion.

Nguyen DC, Garimalla S, Xiao H, Kyu S, Albizua I, Galipeau J, Chiang KY, Waller EK, Wu R, Gibson G, Roberson J, Lund FE, Randall TD, Sanz I, Lee FE.

Nat Commun. 2019 Jan 17;10(1):372. doi: 10.1038/s41467-019-08400-0.

3.

Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.

Krishnamurti L, Neuberg DS, Sullivan KM, Kamani NR, Abraham A, Campigotto F, Zhang W, Dahdoul T, De Castro L, Parikh S, Bakshi N, Haight A, Hassell KL, Loving R, Rosenthal J, Smith SL, Smith W, Spearman M, Stevenson K, Wu CJ, Wiedl C, Waller EK, Walters MC.

Am J Hematol. 2019 Jan 13. doi: 10.1002/ajh.25401. [Epub ahead of print]

PMID:
30637784
4.

Improving cancer-specific outcomes in solid organ transplant recipients: Where to begin?

Koff JL, Waller EK.

Cancer. 2019 Jan 9. doi: 10.1002/cncr.31963. [Epub ahead of print]

PMID:
30624770
5.

Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report.

Funk CR, Petersen CT, Jagirdar N, Ravindranathan S, Jaye DL, Flowers CR, Langston A, Waller EK.

Int J Mol Sci. 2018 Dec 19;19(12). pii: E4118. doi: 10.3390/ijms19124118.

6.

Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation Outcomes.

Hassan M, Ulezko Antonova A, Li JM, Hosoba S, Rupji M, Kowalski J, Perricone AJ, Jaye DL, Marsh H, Yellin M, Devine S, Waller EK.

Biol Blood Marrow Transplant. 2018 Nov 29. pii: S1083-8791(18)30774-2. doi: 10.1016/j.bbmt.2018.11.029. [Epub ahead of print]

PMID:
30503387
7.

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Schuster SJ, Bishop MR, Tam CS, Waller EK, Borchmann P, McGuirk JP, Jäger U, Jaglowski S, Andreadis C, Westin JR, Fleury I, Bachanova V, Foley SR, Ho PJ, Mielke S, Magenau JM, Holte H, Pantano S, Pacaud LB, Awasthi R, Chu J, Anak Ö, Salles G, Maziarz RT; JULIET Investigators.

N Engl J Med. 2019 Jan 3;380(1):45-56. doi: 10.1056/NEJMoa1804980. Epub 2018 Dec 1.

PMID:
30501490
8.

Safety and survival outcomes for bloodless transplantation in patients with myeloma.

Joseph NS, Kaufman JL, Boise LH, Valla K, Almaula DK, Obidike CO, Langston AA, Waller EK, Khoury HJ, Flowers CR, Graiser M, Heffner LT, Lonial S, Nooka AK.

Cancer. 2019 Jan 15;125(2):185-193. doi: 10.1002/cncr.31677. Epub 2018 Nov 27. Review.

PMID:
30480777
9.

Correction: Differential changes in the onset of spring across US National Wildlife Refuges and North American migratory bird flyways.

Waller EK, Crimmins TM, Walker JJ, Posthumus EE, Weltzin JF.

PLoS One. 2018 Nov 26;13(11):e0208348. doi: 10.1371/journal.pone.0208348. eCollection 2018.

10.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL.

Biol Blood Marrow Transplant. 2018 Nov 10. pii: S1083-8791(18)30698-0. doi: 10.1016/j.bbmt.2018.11.004. [Epub ahead of print]

PMID:
30423480
11.

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at 1-year compared to unrelated donors.

Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE.

Haematologica. 2018 Oct 31. pii: haematol.2018.200121. doi: 10.3324/haematol.2018.200121. [Epub ahead of print]

12.

The Potential of CAR T Cell Therapy in Pancreatic Cancer.

Akce M, Zaidi MY, Waller EK, El-Rayes BF, Lesinski GB.

Front Immunol. 2018 Sep 25;9:2166. doi: 10.3389/fimmu.2018.02166. eCollection 2018. Review.

13.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.

Alousi A, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Pidala J, Anderlini P, Boyiadzis M, Bredeson CN, Cahn JY, Cairo MS, Gadalla SM, Hashmi SK, Gale RP, Kanda J, Kamble RT, Kharfan-Dabaja MA, Litzow MR, Ringden O, Saad AA, Schultz KR, Verdonck LF, Waller EK, Yared JA, Holtan SG, Weisdorf DJ.

Biol Blood Marrow Transplant. 2019 Feb;25(2):270-278. doi: 10.1016/j.bbmt.2018.09.004. Epub 2018 Oct 3.

PMID:
30292009
14.

Microfluidic generation of transient cell volume exchange for convectively driven intracellular delivery of large macromolecules.

Liu A, Islam M, Stone N, Varadarajan V, Jeong J, Bowie S, Qiu P, Waller EK, Alexeev A, Sulchek T.

Mater Today (Kidlington). 2018 Sep;21(7):703-712. doi: 10.1016/j.mattod.2018.03.002. Epub 2018 Apr 17.

PMID:
30288138
15.

Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease.

Swimm A, Giver CR, DeFilipp Z, Rangaraju S, Sharma A, Ulezko Antonova A, Sonowal R, Capaldo C, Powell D, Qayed M, Kalman D, Waller EK.

Blood. 2018 Dec 6;132(23):2506-2519. doi: 10.1182/blood-2018-03-838193. Epub 2018 Sep 26.

PMID:
30257880
16.

Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion.

Nguyen DC, Garimalla S, Xiao H, Kyu S, Albizua I, Galipeau J, Chiang KY, Waller EK, Wu R, Gibson G, Roberson J, Lund FE, Randall TD, Sanz I, Lee FE.

Nat Commun. 2018 Sep 12;9(1):3698. doi: 10.1038/s41467-018-05853-7. Erratum in: Nat Commun. 2019 Jan 17;10(1):372.

17.

Differential changes in the onset of spring across US National Wildlife Refuges and North American migratory bird flyways.

Waller EK, Crimmins TM, Walker JJ, Posthumus EE, Weltzin JF.

PLoS One. 2018 Sep 12;13(9):e0202495. doi: 10.1371/journal.pone.0202495. eCollection 2018. Erratum in: PLoS One. 2018 Nov 26;13(11):e0208348.

18.

Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3A rs7588571 and chronic GVHD.

Rashidi A, Shanley R, Anasetti C, Waller EK, Scott BL, Blazar BR, Weisdorf DJ.

Bone Marrow Transplant. 2018 Aug 31. doi: 10.1038/s41409-018-0331-1. [Epub ahead of print] No abstract available.

PMID:
30171221
19.

KIR Donor Selection: Feasibility in Identifying better Donors.

Weisdorf D, Cooley S, Wang T, Trachtenberg E, Haagenson MD, Vierra-Green C, Spellman S, Spahn A, Vogel J, Kobusingye H, Fehninger T, Woolfrey A, Devine S, Ross M, Waller EK, Sobecks R, Parham P, Guethlein LA, Marsh SGE, Miller J; participating center writing committee.

Biol Blood Marrow Transplant. 2019 Jan;25(1):e28-e32. doi: 10.1016/j.bbmt.2018.08.022. Epub 2018 Aug 24.

PMID:
30149149
20.

Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples.

Rashidi A, Shanley R, Yohe SL, Thyagarajan B, Curtsinger J, Anasetti C, Waller EK, Scott BL, Blazar BR, Weisdorf DJ.

Br J Haematol. 2018 Sep;182(6):887-894. doi: 10.1111/bjh.15492. Epub 2018 Jul 13.

PMID:
30004111
21.

A Prospective Trial of Extracorporeal Photopheresis for Chronic Graft-versus-Host Disease Reveals Significant Disease Response and No Association with Frequency of Regulatory T Cells.

Gandelman JS, Song DJ, Chen H, Engelhardt BG, Chen YB, Clark WB, Giver CR, Waller EK, Jung DK, Jagasia M.

Biol Blood Marrow Transplant. 2018 Dec;24(12):2373-2380. doi: 10.1016/j.bbmt.2018.06.035. Epub 2018 Jul 5.

PMID:
29981848
22.

A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801.

Carpenter PA, Logan BR, Lee SJ, Weisdorf DJ, Johnston L, Costa LJ, Kitko CL, Bolaños-Meade J, Sarantopoulos S, Alousi AM, Abhyankar S, Waller EK, Mendizabal A, Zhu J, O'Brien KA, Lazaryan A, Wu J, Nemecek ER, Pavletic SZ, Cutler CS, Horowitz MM, Arora M; BMT CTN.

Haematologica. 2018 Nov;103(11):1915-1924. doi: 10.3324/haematol.2018.195123. Epub 2018 Jun 28.

23.

Circulating Progenitor Cells and Racial Differences.

Samman Tahhan A, Hammadah M, Kelli HM, Kim JH, Sandesara PB, Alkhoder A, Kaseer B, Gafeer MM, Topel M, Hayek SS, O'Neal WT, Obideen M, Ko YA, Liu C, Hesaroieh I, Mahar E, Vaccarino V, Waller EK, Quyyumi AA.

Circ Res. 2018 Aug 3;123(4):467-476. doi: 10.1161/CIRCRESAHA.118.313282.

PMID:
29930146
24.

Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis.

Shah NN, Ahn KW, Litovich C, Fenske TS, Ahmed S, Battiwalla M, Bejanyan N, Dahi PB, Bolaños-Meade J, Chen AI, Ciurea SO, Bachanova V, DeFilipp Z, Epperla N, Farhadfar N, Herrera AF, Haverkos BM, Holmberg L, Hossain NM, Kharfan-Dabaja MA, Kenkre VP, Lazarus HM, Murthy HS, Nishihori T, Rezvani AR, D'Souza A, Savani BN, Ulrickson ML, Waller EK, Sureda A, Smith SM, Hamadani M.

Blood Adv. 2018 Apr 24;2(8):933-940. doi: 10.1182/bloodadvances.2018018531.

25.

Diagnosis of GATA2 haplo-insufficiency in a young woman prompted by pancytopenia with deficiencies of B-cell and dendritic cell development.

Sanyi A, Jaye DL, Rosand CB, Box A, Shanmuganathan C, Waller EK.

Biomark Res. 2018 Mar 21;6:13. doi: 10.1186/s40364-018-0127-x. eCollection 2018.

26.

Impact of the posttransplant lymphoproliferative disorder subtype on survival.

Koff JL, Li JX, Zhang X, Switchenko JM, Flowers CR, Waller EK.

Cancer. 2018 Jun 1;124(11):2327-2336. doi: 10.1002/cncr.31339. Epub 2018 Mar 26.

PMID:
29579330
27.

Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples.

Rashidi A, Shanley R, Yohe SL, Thyagarajan B, Curtsinger J, Anasetti C, Waller EK, Miller JS, Blazar BR, Weisdorf DJ.

Bone Marrow Transplant. 2018 Aug;53(8):1069-1071. doi: 10.1038/s41409-018-0127-3. Epub 2018 Mar 7. No abstract available.

PMID:
29515246
28.

Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes.

Samman Tahhan A, Hammadah M, Raad M, Almuwaqqat Z, Alkhoder A, Sandesara PB, Mohamed-Kelli H, Hayek SS, Kim JH, O'Neal WT, Topel ML, Grant AJ, Sabbak N, Heinl RE, Gafeer MM, Obideen M, Kaseer B, Abdelhadi N, Ko YA, Liu C, Hesaroieh I, Mahar EA, Vaccarino V, Waller EK, Quyyumi AA.

Circ Res. 2018 May 25;122(11):1565-1575. doi: 10.1161/CIRCRESAHA.118.312821. Epub 2018 Mar 7.

PMID:
29514830
29.

Microfluidic cell sorting by stiffness to examine heterogenic responses of cancer cells to chemotherapy.

Islam M, Mezencev R, McFarland B, Brink H, Campbell B, Tasadduq B, Waller EK, Lam W, Alexeev A, Sulchek T.

Cell Death Dis. 2018 Feb 14;9(2):239. doi: 10.1038/s41419-018-0266-x.

30.

Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide.

McCurdy SR, Zhang MJ, St Martin A, Al Malki MM, Bashey A, Gaballa S, Keesler DA, Hamadani M, Norkin M, Perales MA, Reshef R, Rocha V, Romee R, Solh M, Urbano-Ispizua A, Waller EK, Fuchs EJ, Eapen M.

Blood Adv. 2018 Feb 13;2(3):299-307. doi: 10.1182/bloodadvances.2017014829.

31.

Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists.

Petersen CT, Hassan M, Morris AB, Jeffery J, Lee K, Jagirdar N, Staton AD, Raikar SS, Spencer HT, Sulchek T, Flowers CR, Waller EK.

Blood Adv. 2018 Feb 13;2(3):210-223. doi: 10.1182/bloodadvances.2017011254.

32.

Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Hosoba S, Waller EK, Shenvi N, Graiser M, Easley KA, Al-Kadhimi Z, Andoh A, Antun AG, Barclay S, Josephson CD, Koff JL, Khoury HJ, Langston AA, Zimring JC, Roback JD, Giver CR.

Biol Blood Marrow Transplant. 2018 May;24(5):973-982. doi: 10.1016/j.bbmt.2018.01.003. Epub 2018 Jan 4.

33.

Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.

Qayed M, Wang T, Hemmer MT, Spellman S, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Aljurf M, Ayas M, Bitan M, Cairo M, Choi SW, Dandoy C, Delgado D, Gale RP, Hale G, Frangoul H, Kamble RT, Kharfan-Dabaja M, Lehman L, Levine J, MacMillan M, Marks DI, Nishihori T, Olsson RF, Hematti P, Ringden O, Saad A, Satwani P, Savani BN, Schultz KR, Seo S, Shenoy S, Waller EK, Yu L, Horowitz MM, Horan J.

Biol Blood Marrow Transplant. 2018 Mar;24(3):521-528. doi: 10.1016/j.bbmt.2017.11.004. Epub 2017 Nov 16.

PMID:
29155316
34.

Activation of VIP signaling enhances immunosuppressive effect of MDSCs on CMV-induced adaptive immunity.

Forghani P, Petersen CT, Waller EK.

Oncotarget. 2017 Sep 7;8(47):81873-81879. doi: 10.18632/oncotarget.20704. eCollection 2017 Oct 10.

35.

Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.

Kersh AE, Ng S, Chang YM, Sasaki M, Thomas SN, Kissick HT, Lesinski GB, Kudchadkar RR, Waller EK, Pollack BP.

J Clin Pharmacol. 2018 Jan;58(1):7-24. doi: 10.1002/jcph.1028. Epub 2017 Nov 14. Review.

36.

Circulating progenitor cells in patients with familial hypercholesterolemia.

Sandesara PB, Ramjee V, Ghasemzadeh N, Guo Y, Bhatia N, Li Q, Vaughn L, Nell-Dybdahl C, Waller EK, Mahar EA, Brigham K, Wilson PWF, Quyyumi A, Le NA, Sperling LS.

J Clin Apher. 2018 Jun;33(3):404-408. doi: 10.1002/jca.21601. Epub 2017 Nov 8.

PMID:
29114919
37.

Sex Differences in Circulating Progenitor Cells.

Topel ML, Hayek SS, Ko YA, Sandesara PB, Samman Tahhan A, Hesaroieh I, Mahar E, Martin GS, Waller EK, Quyyumi AA.

J Am Heart Assoc. 2017 Oct 3;6(10). pii: e006245. doi: 10.1161/JAHA.117.006245.

38.

PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.

Hossain MS, Kunter GM, El-Najjar VF, Jaye DL, Al-Kadhimi Z, Taofeek OK, Li JM, Waller EK.

PLoS One. 2017 Sep 27;12(9):e0184254. doi: 10.1371/journal.pone.0184254. eCollection 2017.

39.

Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.

Miklos D, Cutler CS, Arora M, Waller EK, Jagasia M, Pusic I, Flowers ME, Logan AC, Nakamura R, Blazar BR, Li Y, Chang S, Lal I, Dubovsky J, James DF, Styles L, Jaglowski S.

Blood. 2017 Nov 23;130(21):2243-2250. doi: 10.1182/blood-2017-07-793786. Epub 2017 Sep 18.

40.

Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.

Samman Tahhan A, Hammadah M, Sandesara PB, Hayek SS, Kalogeropoulos AP, Alkhoder A, Mohamed Kelli H, Topel M, Ghasemzadeh N, Chivukula K, Ko YA, Aida H, Hesaroieh I, Mahar E, Kim JH, Wilson P, Shaw L, Vaccarino V, Waller EK, Quyyumi AA.

Circ Heart Fail. 2017 Aug;10(8). pii: e004106. doi: 10.1161/CIRCHEARTFAILURE.117.004106. Epub 2017 Aug 8.

41.

Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia.

Dhere V, Edelman S, Waller EK, Langston A, Graiser M, Connolly EC, Switchenko JM, Esiashvili N, Khan MK.

Leuk Lymphoma. 2018 Apr;59(4):837-843. doi: 10.1080/10428194.2017.1361027. Epub 2017 Aug 7.

42.

Building blocks for institutional preparation of CTL019 delivery.

McGuirk J, Waller EK, Qayed M, Abhyankar S, Ericson S, Holman P, Keir C, Myers GD.

Cytotherapy. 2017 Sep;19(9):1015-1024. doi: 10.1016/j.jcyt.2017.06.001. Epub 2017 Jul 25. Review.

43.

Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ priming.

Chinnadurai R, Rajan D, Ng S, McCullough K, Arafat D, Waller EK, Anderson LJ, Gibson G, Galipeau J.

Blood Adv. 2017 Apr 25;1(11):628-643. doi: 10.1182/bloodadvances.2017006205.

44.

Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.

Petersen CT, Li JM, Waller EK.

Oncoimmunology. 2017 Mar 16;6(5):e1304336. doi: 10.1080/2162402X.2017.1304336. eCollection 2017.

45.

Microfluidic Sorting of Cells by Viability Based on Differences in Cell Stiffness.

Islam M, Brink H, Blanche S, DiPrete C, Bongiorno T, Stone N, Liu A, Philip A, Wang G, Lam W, Alexeev A, Waller EK, Sulchek T.

Sci Rep. 2017 May 17;7(1):1997. doi: 10.1038/s41598-017-01807-z.

46.

Mobilizing plasmacytoid dendritic cells.

Waller EK.

Blood. 2017 May 11;129(19):2600-2602. doi: 10.1182/blood-2017-03-774703. No abstract available.

47.

Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study.

Shah NN, McClellan W, Flowers CR, Lonial S, Khoury H, Waller EK, Langston A, Nooka AK.

Infect Control Hosp Epidemiol. 2017 Jun;38(6):651-657. doi: 10.1017/ice.2017.12. Epub 2017 Mar 23.

PMID:
28330512
48.

Bioactive Lipids and Circulating Progenitor Cells in Patients with Cardiovascular Disease.

Hayek SS, Klyachkin Y, Asfour A, Ghasemzadeh N, Awad M, Hesaroieh I, Ahmed H, Gray B, Kim J, Waller EK, Quyyumi AA, Abdel-Latif AK.

Stem Cells Transl Med. 2017 Mar;6(3):731-735. doi: 10.5966/sctm.2016-0059. Epub 2016 Oct 14.

49.

GM-CSF and IL-4 Fusion Cytokine Induces B Cell-Dependent Hematopoietic Regeneration.

Deng J, Li Y, Pennati A, Yuan S, Wu JH, Waller EK, Galipeau J.

Mol Ther. 2017 Feb 1;25(2):416-426. doi: 10.1016/j.ymthe.2016.11.013.

50.

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.

Boyiadzis M, Bishop MR, Abonour R, Anderson KC, Ansell SM, Avigan D, Barbarotta L, Barrett AJ, Van Besien K, Bergsagel PL, Borrello I, Brody J, Brufsky J, Cairo M, Chari A, Cohen A, Cortes J, Forman SJ, Friedberg JW, Fuchs EJ, Gore SD, Jagannath S, Kahl BS, Kline J, Kochenderfer JN, Kwak LW, Levy R, de Lima M, Litzow MR, Mahindra A, Miller J, Munshi NC, Orlowski RZ, Pagel JM, Porter DL, Russell SJ, Schwartz K, Shipp MA, Siegel D, Stone RM, Tallman MS, Timmerman JM, Van Rhee F, Waller EK, Welsh A, Werner M, Wiernik PH, Dhodapkar MV.

J Immunother Cancer. 2016 Dec 20;4:90. doi: 10.1186/s40425-016-0188-z. eCollection 2016.

Supplemental Content

Loading ...
Support Center